The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.23

Today's change+1.51 +2.33%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.23

Today's change+1.51 +2.33%
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc Hits New 100-day High

AbbVie Inc closed up sharply Friday, rallying (U.S.)$1.51 or 2.33% to (U.S.)$66.23 and setting a new 100-day high. Over the last five days, shares have gained 3.79% and 11.80% year to date. Shares have underperformed the S&P 500 by 9.50% during the last year.

Key company metrics

  • Open(U.S.) $65.27
  • Previous close(U.S.) $64.72
  • High(U.S.) $66.40
  • Low(U.S.) $65.15
  • Bid / Ask-- / --
  • YTD % change+11.80%
  • Volume10,525,016
  • Average volume (10-day)6,856,916
  • Average volume (1-month)7,863,650
  • Average volume (3-month)8,207,192
  • 52-week range(U.S.) $45.45 to (U.S.) $71.51
  • Beta1.48
  • Trailing P/E19.84×
  • P/E 1 year forward13.90×
  • Forward PEG0.86×
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield3.44%
  • Trailing EPS(U.S.) $3.34
Updated July 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue5,9586,4005,9445,475
Total other revenue--------
Total revenue5,9586,4005,9445,475
Gross profit4,6274,9254,8664,559
Total cost of revenue1,3311,4751,078916
Total operating expense3,6804,2874,0593,623
Selling / general / administrative1,3551,7371,4741,703
Research & development9461,0751,418981
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)490023
Other operating expenses, total--00--
Operating income2,2782,1131,8851,852
Interest income (expense), net non-operating-215-208-207-172
Gain (loss) on sale of assets--------
Other--------
Income before tax1,7761,9241,6471,678
Income after tax1,3541,5171,2391,366
Income tax, total422407408312
Net income1,3541,5171,2391,366
Total adjustments to net income--------
Net income before extra. items1,3541,5171,2391,366
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3541,5171,2391,366
Inc. avail. to common incl. extra. items1,3541,5171,2391,366
Diluted net income1,3541,5171,2391,366
Dilution adjustment--------
Diluted weighted average shares1,6251,6431,6641,633
Diluted EPS excluding extraordinary itemsvalue per share0.830.920.740.84
Dividends per sharevalue per share0.570.570.510.51
Diluted normalized EPSvalue per share0.860.920.740.85